IL159827A0 - Biologically active peptides - Google Patents

Biologically active peptides

Info

Publication number
IL159827A0
IL159827A0 IL15982702A IL15982702A IL159827A0 IL 159827 A0 IL159827 A0 IL 159827A0 IL 15982702 A IL15982702 A IL 15982702A IL 15982702 A IL15982702 A IL 15982702A IL 159827 A0 IL159827 A0 IL 159827A0
Authority
IL
Israel
Prior art keywords
biologically active
active peptides
disclosed
nucleic acids
pharmaceutical formulation
Prior art date
Application number
IL15982702A
Other languages
English (en)
Original Assignee
Pepharm R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepharm R & D Ltd filed Critical Pepharm R & D Ltd
Publication of IL159827A0 publication Critical patent/IL159827A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL15982702A 2001-07-13 2002-07-11 Biologically active peptides IL159827A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90449201A 2001-07-13 2001-07-13
PCT/GB2002/003203 WO2003006492A2 (fr) 2001-07-13 2002-07-11 Peptides exerçant une activite biologique

Publications (1)

Publication Number Publication Date
IL159827A0 true IL159827A0 (en) 2004-06-20

Family

ID=25419251

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15982702A IL159827A0 (en) 2001-07-13 2002-07-11 Biologically active peptides
IL184227A IL184227A (en) 2001-07-13 2007-06-26 Biologically active peptides, a genetic vector from an organism containing a nucleotide sequence encoding the peptides, medicinal preparations containing the peptides, a method for preparing and using these medicinal preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL184227A IL184227A (en) 2001-07-13 2007-06-26 Biologically active peptides, a genetic vector from an organism containing a nucleotide sequence encoding the peptides, medicinal preparations containing the peptides, a method for preparing and using these medicinal preparations

Country Status (24)

Country Link
EP (3) EP1947109A3 (fr)
JP (3) JP4213581B2 (fr)
KR (2) KR100889992B1 (fr)
AT (2) ATE466871T1 (fr)
AU (1) AU2002319423B2 (fr)
BR (1) BR0210252A (fr)
CA (2) CA2452417C (fr)
DE (2) DE60229883D1 (fr)
DK (2) DK1790655T3 (fr)
ES (2) ES2316586T3 (fr)
HK (2) HK1066552A1 (fr)
IL (2) IL159827A0 (fr)
MX (1) MXPA03011190A (fr)
MY (1) MY138219A (fr)
NO (2) NO332061B1 (fr)
NZ (3) NZ544079A (fr)
PL (2) PL211884B1 (fr)
PT (2) PT1790655E (fr)
RU (2) RU2305107C2 (fr)
SA (1) SA04240478B1 (fr)
SG (2) SG185137A1 (fr)
UA (1) UA83989C2 (fr)
WO (1) WO2003006492A2 (fr)
ZA (2) ZA200401108B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1213062C (zh) 2001-07-13 2005-08-03 一泰医药研究（深圳）有限公司 序列号13的生物活性肽
US20060167229A1 (en) * 2002-12-18 2006-07-27 Wai Ming Wong Biologically active peptide conjugates
TWI322815B (en) * 2003-06-26 2010-04-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide comprising tyrosyl-seryl-valine (ysv)
TWI353252B (en) 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
CN1799623B (zh) * 2005-01-05 2011-01-26 康哲医药研究(深圳)有限公司 生物活性肽在制备用于防治关节炎的药物中的用途
EP1909815A4 (fr) 2005-07-26 2011-05-18 Cms Peptides Patent Holding Company Ltd Nouveaux peptides biologiquement actifs et leurs nouvelles utilisations
GB0918579D0 (en) * 2009-10-22 2009-12-09 Imp Innovations Ltd Gadd45beta targeting agents
RU2615908C1 (ru) * 2016-05-16 2017-04-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ моделирования лимфогенного и гематогенного метастазирования мышиной меланомы В16 у белых нелинейных крыс

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
WO1991009613A1 (fr) * 1989-12-22 1991-07-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Peptides synthetiques utilises comme modulateurs des reactions fonctionnelles de cellules intactes
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
ATE253635T1 (de) 1993-06-15 2003-11-15 Du Pont Rekombinante spinnerseide analoge
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
JPH10503643A (ja) 1994-06-17 1998-04-07 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー 微生物中に遺伝物質を導入する方法およびその方法によってえられる形質転換体
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US5958416A (en) * 1994-12-16 1999-09-28 Regents Of The University Of Minnesota Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP0867450B1 (fr) 1995-10-24 2004-08-11 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Peptides TFPI-associés lesquels inhibent la croissance des cellules musculaires lisses
GB9606016D0 (en) * 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
WO1998054339A1 (fr) 1997-05-27 1998-12-03 Hanil Synthetic Fiber Co., Ltd. TECHNIQUE DE MISE AU POINT DE PROTEINES DE RECOMBINAISON FAISANT INTERVENIR UN VECTEUR D'EXPRESSION DES PLUS EFFICACE ISSU DE $i(SACCHAROMYCES CEREVISIAE)
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
WO2000013025A1 (fr) * 1998-08-31 2000-03-09 University Of Washington Marquage metabolique au moyen d'isotopes stables afin d'analyser des biopolymeres
US6413530B1 (en) * 1999-04-21 2002-07-02 University Of Florida Research Foundation, Inc. Pesticidal peptides
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
AU1197001A (en) * 1999-10-29 2001-05-14 Institute For Applied Biomedicine B cell clonal toxins and methods for using the same

Also Published As

Publication number Publication date
NO20073914L (no) 2004-03-10
BR0210252A (pt) 2004-09-14
EP1790655A2 (fr) 2007-05-30
HK1066552A1 (en) 2005-03-24
RU2004104335A (ru) 2005-03-27
ATE466871T1 (de) 2010-05-15
PL208666B1 (pl) 2011-05-31
DE60236330D1 (de) 2010-06-17
WO2003006492A2 (fr) 2003-01-23
DE60229883D1 (de) 2008-12-24
JP4316651B2 (ja) 2009-08-19
CA2707767A1 (fr) 2003-01-23
ES2345842T3 (es) 2010-10-04
KR100889992B1 (ko) 2009-03-25
CA2707767C (fr) 2013-09-03
EP1790655B1 (fr) 2010-05-05
CA2452417C (fr) 2013-08-20
NO332061B1 (no) 2012-06-11
JP4213581B2 (ja) 2009-01-21
EP1947109A3 (fr) 2008-10-01
SA04240478B1 (ar) 2007-07-31
PL211884B1 (pl) 2012-07-31
WO2003006492A3 (fr) 2003-12-31
KR20070070258A (ko) 2007-07-03
PL368059A1 (en) 2005-03-21
RU2007108896A (ru) 2008-09-20
NZ544079A (en) 2007-10-26
ZA200401108B (en) 2006-05-31
CA2452417A1 (fr) 2003-01-23
PT1478659E (pt) 2009-01-02
IL184227A (en) 2010-06-16
ATE414099T1 (de) 2008-11-15
EP1947109A2 (fr) 2008-07-23
AU2002319423B2 (en) 2008-02-14
EP1478659B1 (fr) 2008-11-12
HK1098767A1 (en) 2007-07-27
EP1790655A3 (fr) 2007-10-10
RU2425053C2 (ru) 2011-07-27
DK1790655T3 (da) 2010-08-23
RU2305107C2 (ru) 2007-08-27
EP1478659A2 (fr) 2004-11-24
KR20040019058A (ko) 2004-03-04
KR100889993B1 (ko) 2009-03-25
SG185137A1 (en) 2012-11-29
IL184227A0 (en) 2007-10-31
DK1478659T3 (da) 2009-01-05
JP2004533846A (ja) 2004-11-11
SG142165A1 (en) 2008-05-28
JP2008263993A (ja) 2008-11-06
JP2007312785A (ja) 2007-12-06
MXPA03011190A (es) 2004-10-28
UA83989C2 (ru) 2008-09-10
MY138219A (en) 2009-05-29
NO20040134L (no) 2004-03-10
ZA200509838B (en) 2007-11-28
ES2316586T3 (es) 2009-04-16
NZ553507A (en) 2008-07-31
PT1790655E (pt) 2010-07-09
NZ529879A (en) 2007-12-21

Similar Documents

Publication Publication Date Title
IL184227A0 (en) Biologically active peptides
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60032367D1 (de) Aktivierbare rekombinante neurotoxine
WO2003074551A8 (fr) Conjugues d'agents therapeutiques ou cytotoxiques et de peptides bioactifs
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
BR0312889A (pt) Polipeptìdeo t20 peguilado
GB2411404A (en) Biologically active peptide conjugates
ZA200205408B (en) Process for the preparation of peptides.
WO2001053453A8 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
TW200611913A (en) Biologically active peptides (Ⅲ)
WO2001092468A3 (fr) Nouvelles compositions pour l'expression du transporteur 1 d'histidine de peptide humain et leurs procedes d'utilisation
WO2001029084A3 (fr) Nouvelles proteines humaines et polynucleotides codant pour ces memes proteines
WO2002066513A3 (fr) Fragments humains de lekti circulants hf7072, hf7638 et hf14448 ainsi que leur utilisation
IL153674A0 (en) 13-substituted methacycline compounds
EP1591448A3 (fr) Nouveaux acides nucleiques et polypeptides
CA2530618A1 (fr) Nouveau canal calcique
WO2001019850A3 (fr) Acides nucleiques et polypeptides nrage, et leurs utilisations
TWI318631B (en) Biologically active peptides
AU2001227101A1 (en) Wt1-interacting protein wtip
AU2002303821A1 (en) Aryl-8-azabicyclo(3.2.1)octanes for the treatment of depression

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed